ATAI Life Sciences N.V.
Develops psychedelic-inspired therapies for mental health disorders.
ATAI | US
Overview
Corporate Details
- ISIN(s):
- NL0015000DX5
- LEI:
- Country:
- United States of America
- Address:
- PROF. J.H. BAVINCKLAAN 7, 1183 AMSTELVEEN
- Website:
- https://atai.life/
- Sector:
- Manufacturing
Description
AtaiBeckley is a clinical-stage biopharmaceutical company focused on developing innovative treatments for mental health disorders. Following a strategic combination with Beckley Psytech, the company advances a pipeline of psychedelic-inspired therapies, including hallucinogens and entactogens. Its mission is to address significant unmet needs in mental health by creating effective, rapid-acting, and convenient evidence-based treatments. The company targets a range of psychiatric conditions, such as depression and schizophrenia, with the goal of transforming patient outcomes on a large scale.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ATAI Life Sciences N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ATAI Life Sciences N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ATAI Life Sciences N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
